相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer's Disease
Malin Olsen et al.
MOLECULAR IMAGING AND BIOLOGY (2018)
Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid- β
Kyle J. Korshavn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes
Gabriel Gustafsson et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor
Greta Hultqvist et al.
THERANOSTICS (2017)
Towards an understanding of amyloid-β oligomers: characterization, toxicity mechanisms, and inhibitors
Shin Jung C. Lee et al.
CHEMICAL SOCIETY REVIEWS (2017)
Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons
Sofia Sollvander et al.
MOLECULAR NEURODEGENERATION (2016)
Safety and tolerability of BAN2401-a clinical study in Alzheimer's disease with a protofibril selective Aβ antibody
Veronika Logovinsky et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Why are Astrocytes Important?
Alexei Verkhratsky et al.
NEUROCHEMICAL RESEARCH (2015)
How Do Membranes Initiate Alzheimer's Disease? Formation of Toxic Arnyloid Fibrils by the Amyloid β-Protein on Ganglioside Clusters
Katsumi Matsuzaki
ACCOUNTS OF CHEMICAL RESEARCH (2014)
Differences between amyloid-beta aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease
Samuel A. Kotler et al.
CHEMICAL SOCIETY REVIEWS (2014)
Acute isolation and transcriptome characterization of cortical astrocytes and microglia from young and aged mice
Marie Orre et al.
NEUROBIOLOGY OF AGING (2014)
The dual role of astrocyte activation and reactive gliosis
Milos Pekny et al.
NEUROSCIENCE LETTERS (2014)
Perspectives on future Alzheimer therapies: amyloid-beta protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer's disease
Lars Lannfelt et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia
Lisa Fellner et al.
GLIA (2013)
Amyloid-β-Induced Astrocytic Phagocytosis is Mediated by CD36, CD47 and RAGE
Raasay S. Jones et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Effects of altered FcγR binding on antibody pharmacokinetics in cynomolgus monkeys
Maya K. Leabman et al.
MABS (2013)
Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways
Won-Suk Chung et al.
NATURE (2013)
The lysosome: from waste bag to potential therapeutic target
Hanna Appelqvist et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2013)
Soluble Aβ Promotes Wild-Type Tau Pathology In Vivo
Meredith A. Chabrier et al.
JOURNAL OF NEUROSCIENCE (2012)
A mutation in APP protects against Alzheimer's disease and age-related cognitive decline
Thorlakur Jonsson et al.
NATURE (2012)
Large Aggregates Are the Major Soluble Ab Species in AD Brain Fractionated with Density Gradient Ultracentrifugation
Dag Sehlin et al.
PLOS ONE (2012)
Brain-specific angiogenesis inhibitor-1 expression in astrocytes and neurons: Implications for its dual function as an apoptotic engulfment receptor
Jennifer D. Sokolowski et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Membrane and surface interactions of Alzheimer's Aβ peptide - insights into the mechanism of cytotoxicity
Thomas L. Williams et al.
FEBS JOURNAL (2011)
Heavy-Chain Complementarity-Determining Regions Determine Conformation Selectivity of Anti-A beta Antibodies
Dag Sehlin et al.
NEURODEGENERATIVE DISEASES (2011)
Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
Ming Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Astrocytes: biology and pathology
Michael V. Sofroniew et al.
ACTA NEUROPATHOLOGICA (2010)
Interference from Heterophilic Antibodies in Amyloid-beta Oligomer ELISAs
Dag Sehlin et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Blood-Borne Amyloid-β Dimer Correlates with Clinical Markers of Alzheimer's Disease
Victor L. Villemagne et al.
JOURNAL OF NEUROSCIENCE (2010)
Regulation of synaptic connectivity by glia
Cagla Eroglu et al.
NATURE (2010)
Astrocytes and Therapeutics for Parkinson's Disease
Phillip M. Rappold et al.
NEUROTHERAPEUTICS (2010)
Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease
Kwasi G. Mawuenyega et al.
SCIENCE (2010)
An amyloid-β protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease
Anna Lord et al.
NEUROBIOLOGY OF DISEASE (2009)
The Role of Apolipoprotein E in Alzheimer's Disease
Jungsu Kim et al.
NEURON (2009)
Neurodegenerative lysosomal disorders - A continuum from development to late age
Ralph A. Nixon et al.
AUTOPHAGY (2008)
Potency and Fate Specification in CNS Stem Cell Populations In Vitro
Rea Ravin et al.
CELL STEM CELL (2008)
Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors
Stephen L. Sazinsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Aβ oligomer-mediated long-term potentiation impairment involves protein phosphatase 1-dependent mechanisms
Marlen Knobloch et al.
JOURNAL OF NEUROSCIENCE (2007)
Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway
Ganesh M. Shankar et al.
JOURNAL OF NEUROSCIENCE (2007)
Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease
Pascale N. Lacor et al.
JOURNAL OF NEUROSCIENCE (2007)
Increase in beta-amyloid levels in cerebrospinal fluid of children with down syndrome
Hillevi Englund et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Effects of secreted oligomers of amyloid β-protein on hippocampal synaptic plasticity:: a potent role for trimers
M Townsend et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Small non-fibrillar assemblies of amyloid β-protein bearing the Arctic mutation induce rapid neuritic degeneration
BM Whalen et al.
NEUROBIOLOGY OF DISEASE (2005)
Amyloid-β oligomers are inefficiently measured by enzyme-linked immunosorbent assay
C Stenh et al.
ANNALS OF NEUROLOGY (2005)
Soluble Arctic amyloid β protein inhibits hippocampal long-term potentiation in vivo
I Klyubin et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Astrocytes accumulate Aβ42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains
RG Nagele et al.
BRAIN RESEARCH (2003)
Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology
F Bard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Astrocytes are less efficient in the removal of apoptotic lymphocytes than microglia cells: Implications for the role of glial cells in the inflamed central nervous system
T Magnus et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)